Beryl Drugs Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Beryl Drugs Ltd is ₹ 23.02 as of 12 Jun 15:30 . The P/E Ratio of Beryl Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Beryl Drugs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 20003 crore on March 2025 to ₹ 20003 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Beryl Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of OneSource Specialty Pharma Ltd for the Mar '26 is ₹ 430.34 crore as compare to the Dec '25 revenue of ₹ 294.97 crore. This represent the growth of 45.89% The ebitda of Beryl Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of OneSource Specialty Pharma Ltd for the Mar '26 is ₹ 94.05 crore as compare to the Dec '25 ebitda of ₹ 14.86 crore. This represent the growth of 532.91% The net profit of Beryl Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -5.55 crore to ₹ 4.6 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beryl Drugs Ltd

Beryl Drugs Limited was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V. fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.

About OneSource Specialty Pharma Ltd

Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

FAQs for the comparison of Beryl Drugs Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Beryl Drugs Ltd or OneSource Specialty Pharma Ltd?

Market cap of Beryl Drugs Ltd is 11 Cr while Market cap of OneSource Specialty Pharma Ltd is 18,496 Cr

What are the key factors driving the stock performance of Beryl Drugs Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Beryl Drugs Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beryl Drugs Ltd and OneSource Specialty Pharma Ltd?

As of June 15, 2026, the Beryl Drugs Ltd stock price is INR ₹23.02. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1613.4.

How do dividend payouts of Beryl Drugs Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Beryl Drugs Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.